AnnJi Pharmaceutical Investors
Dedicated to New Drug Development in Dermatology & Neurology
Major Investors
- Taiwania Capital
- Fubon Financial Holding Venture Capital Corp.
- Mega International Commercial Bank
- SinoPac Venture Capital
- Orient EuroPharma Co., Ltd.
- Eminent III Venture Capital Corp.
- Saga Unitek Venture
- Taiwan Cooperative Venture Capital
- President International Development Corp.
- Hardy W. Chan and Sons, LLC
- AndroScience Corp.
- Cathay Venture Inc.
- Taiwania Capital
- Fubon Financial Holding Venture Capital Corp.
- Mega International Commercial Bank
- SinoPac Venture Capital
- Orient EuroPharma Co., Ltd.
- Eminent III Venture Capital Corp.
- Saga Unitek Venture
- Taiwan Cooperative Venture Capital
- President International Development Corp.
- Hardy W. Chan and Sons, LLC
- AndroScience Corp.
- Cathay Venture Inc.
Previous
Next
Investor Relations
Lewis Yeh, CFO
+886-2-2365-5677 ext. 200
lewis.yeh@ajpharm.com
Taiwan’s leading new drug developer in dermatology & neurology
Translation and development of new chemical entities from lead optimization, candidate selection to clinical proof-of-concept
